Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Magkou, D., & Tziomalos K. (2014).  Antidiabetic treatment, stroke severity and outcome.. World J Diabetes. 5(2), 84-8.
Addabbo, F., Baglioni V., Schrag A., Schwarz M. J., Dietrich A., Hoekstra P. J., et al. (2020).  Anti-dopamine D2 receptor antibodies in chronic tic disorders.. Dev Med Child Neurol. 62(10), 1205-1212.
Fountoulakis, K. N., Gonda X., Samara M., Siapera M., Karavelas V., Ristic D. I., et al. (2012).  Antiepileptic drugs and suicidality.. J Psychopharmacol. 26(11), 1401-7.
Siamouli, M., Samara M., & Fountoulakis K. N. (2014).  Is antiepileptic-induced suicidality a data-based class effect or an exaggeration? A comment on the literature.. Harv Rev Psychiatry. 22(6), 379-81.
Hostettler, K. E., Zhong J., Papakonstantinou E., Karakiulakis G., Tamm M., Seidel P., et al. (2014).  Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis.. Respir Res. 15, 157.
Saoulidis, S., Simitsopoulou M., Dalakiouridou M., Walsh T. J., L Wheat J., Papaioannidou P., et al. (2011).  Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model.. Mycoses. 54(5), e486-92.
Saoulidis, S., Simitsopoulou M., Dalakiouridou M., Papaioannidou P., & Roilides E. (2008).  Antifungal Activity of Posaconazole and Granulocyte Colony-Stimulating Factor in the Treatment of Disseminated Zygomycosis in a Neutropenic Murine Model. International Journal of Infectious Diseases. 12, S48.
Rizava, C., Bekiari E., Liakos A., Sarigianni M., Rika M., Haidich A. Bettina, et al. (2016).  Antigen-based immunotherapies do not prevent progression of recent-onset autoimmune diabetes: a systematic review and meta-analysis. Endocrine. 541493253564319603435853315343646323232332378366375452107937693091093863(331029229844492951104144411978855372514249), 620 - 633.
Dionyssiou, D., & Demiri E. (2008).  Antihelix, antehelix or anthelix? Comments on ‘Upping the Anti?’. Journal of Plastic, Reconstructive & Aesthetic Surgery. 61(10), 1231.
Dionyssiou, D., & Demiri E. (2008).  Antihelix, antehelix or anthelix? Comments on 'Upping the Anti?'.. J Plast Reconstr Aesthet Surg. 61(10), 1231.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2018).  Antihypertensive drug treatment: the real-life challenge.. J Clin Hypertens (Greenwich). 20(1), 115-117.
Boutari, C., Stavropoulos K., Imprialos K. P., Petidis K., & Doumas M. (2016).  Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Nonadherence?. Am J Hypertens. 29(5), 662.
Nikolaidou, B., Lazaridis A., & Doumas M. (2014).  Antihypertensive therapy after acute ischemic stroke.. JAMA. 311(22), 2333-4.
Georgianou, E., Georgianos P. I., Petidis K., Athyros V. G., Sarafidis P. A., & Karagiannis A. (2018).  Antihypertensive therapy in acute ischemic stroke: where do we stand?. J Hum Hypertens. 32(12), 799-807.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2009).  Anti-inflammatory effects of fibrates: an overview.. Curr Med Chem. 16(6), 676-84.
Kirmizis, D., Papagianni A., Dogrammatzi F., Efstratiadis G., & Memmos D. (2013).  Anti-inflammatory effects of simvastatin in diabetic compared to non-diabetic patients on chronic hemodialysis.. J Diabetes. 5(4), 492-4.
Deftereos, S., Giannopoulos G., Angelidis C., Alexopoulos N., Filippatos G., Papoutsidakis N., et al. (2015).  Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.. Circulation. 132(15), 1395-403.
Sfoungaris, D., Magdalini M., Patoulias I., Panteli C., & Valioulis I. (2018).  Antimesenteric gastrointestinal tract duplication undergoing non-ulcerative perforation.. Rom J Morphol Embryol. 59(4), 1275-1278.
Kontou, A., Sarafidis K., & Roilides E. (2017).  Antimicrobial dosing in neonates.. Expert Rev Clin Pharmacol. 10(3), 239-242.
Chatedaki, C., Voulgaridi I., Kachrimanidou M., Hrabak J., Papagiannitsis C. C., & Petinaki E. (2019).  Antimicrobial susceptibility and mechanisms of resistance of Greek Clostridium difficile clinical isolates.. J Glob Antimicrob Resist. 16, 53-58.
Tolikas, A., Tsakos E., Gerou S., Prapas Y., & Loufopoulos A. (2011).  Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.. Hum Fertil (Camb). 14(4), 246-53.
Piouka, A., Farmakiotis D., Katsikis I., Macut D., Gerou S., & Panidis D. (2009).  Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.. Am J Physiol Endocrinol Metab. 296(2), E238-43.
Apostolidis, A. (2015).  Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?. Curr Drug Targets. 16(11), 1187-97.
Poulas, K., Koutsouraki E., Kordas G., Kokla A., & Tzartos S. J. (2012).  Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.. J Neuroimmunol. 250(1-2), 94-8.
Lekakis, J., Dimopoulos M., Nanas J., Prassopoulos V., Agapitos N., Alexopoulos G., et al. (1997).  Antimyosin scintigraphy for detection of cardiac amyloidosis.. Am J Cardiol. 80(7), 963-5.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές